课题基金 / 基金详情

Development of novel therapy for heart failure using Cdk9 as a target molecule

Development of novel therapy for heart failure using Cdk9 as a target molecule
使用 Cdk9 作为靶分子开发心力衰竭新疗法
批准号:
18390239
负责人:
SANO Motoaki
金额:
$11.36万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007

项目摘要

项目成果

SANO Motoaki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Intramolecular control of protein stability, subnuclear compartmentalization, and coactivator function of peroxisome proliferator-activated receptor gamma coactivator 1alphaPeroxisome proliferator-activated receptor gamma coactivator (PGC)-1 is a critical transcriptional regulator of energy metabolism. Here we found that PGC-1alpha is a short lived and aggregation-prone protein. PGC-1alpha localized throughout the nucleoplasm and was rapidly destroyed via the ubiquitin-proteasome pathway. Upon proteasome inhibition, PGC-1alpha formed insoluble polyubiquitinated aggregates. Ubiquitination of PGC-1alpha depended on the integrity of the C terminus-containing arginine-serine-rich domains and an RNA recognition motif. Interestingly, ectopically expressed C-terminal fragment of PGC-1alpha was autonomously ubiquitinated and aggregated with promyelocytic leukemia protein. Cooperation of the N-terminal region containing two PEST-like motifs was required for prevention of aggregation and targeti … More ng of the polyubiquitinated PGC-1alpha for degradation. This region thereby negatively controlled the aggregation properties of the C-terminal region to regulate protein turnover and intranuclear compartmentalization of PGC-1alpha Exogenous expression of the PGC-1alpha C-terminal fragment interfered with degradation of full-length PGC-1alpha and enhanced its coactivation properties. We concluded that PGC-1alpha function is critically regulated at multiple steps via intramolecular cooperation among several distinct structural domains of the protein.HEXIM-1 alleviated hypoxia-induced right ventricular hypertrophyHEXIM-1 is an endogenous inhibitor of Cdk9. To examine the effect of Cdk9 inhibition on the development of cardiac hypertrophy, we developed loss of function model of Cdk9 activity by transgenic over-expression of HEXIM-1. Cardiac-specific HEXIM-1 TG mice and wild-type littermates were subjected to hypoxia (11% O_2). Right ventricular hypertrophy produced by hypoxia was milder in HEXIM-1 TG mice compared to wild-type littermates. Less
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
転写共役因子PPARg coactivator-1(PGC-1)の細胞内局在とタンパクレベルの制御機構
转录共激活因子PPARg coactivator-1 (PGC-1)的亚细胞定位和蛋白水平控制机制
DOI: --
发表时间: 2007
期刊:
影响因子: --
作者: [Ieda M, kanazawa H, Sano M, 佐野 元昭, Motoaki Sano, 佐野 元昭]
通讯作者: 佐野 元昭
DOI: 10.1161/circulationaha.106.650903
发表时间: 2007-09-04
期刊: CIRCULATION
影响因子: 37.8
作者: [Endo, Jin, Sano, Motoaki, Fukuda, Keiichi]
通讯作者: Fukuda, Keiichi
Menage-a-trois 1 is indisoensable for the transcriptional function of PPARy coactivatior-1
Menage-a-trois 1 与 PPARy coactivatior-1 的转录功能密不可分
DOI: --
发表时间: 2007
期刊: Cell Metabolism 5
影响因子: --
作者: [Sano, M, Izumu, Y, et. al.]
通讯作者: et. al.
ミトコンドリアと転写制御からみた循環器疾患
从线粒体和转录调控的角度看心血管疾病
DOI: --
发表时间: 2006
期刊: 実験医学 増刊 疾患のサイエンス Vo1.24-No.10
影响因子: --
作者: [佐野元昭, 福田恵一]
通讯作者: 福田恵一
16
    Elucidation of the molecular mechanism and regulation of T-cell senescence
    • 批准号:
      18H02812
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.15万
    • 财政年份:
      2018
    • 负责人:
      SANO Motoaki
    • 依托单位:
    Cellular mechanism of cardio-adrenal interaction
    • 批准号:
      25670396
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2013
    • 负责人:
      SANO Motoaki
    • 依托单位:
    PGD2-CRTH2 pathway promotes tubulointerstitial fibrosis
    • 批准号:
      24659395
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2012
    • 负责人:
      SANO Motoaki
    • 依托单位:
    A significance of integrated stress response in the heart
    • 批准号:
      22659158
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.07万
    • 财政年份:
      2010
    • 负责人:
      SANO Motoaki
    • 依托单位:
    国内基金
    海外基金
    利用CRISPR内源性激活Atoh1转录促进前庭毛细胞再生和功能重建
    • 批准号:
      82371145
    • 项目类别:
      面上项目
    • 资助金额:
      46.00万元
    • 批准年份:
      2023
    • 负责人:
      陶永
    • 依托单位:
    转录因子BCL6抑制ICOSL表达优化生发中心反应的机制研究
    • 批准号:
      82371745
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      张文倩
    • 依托单位:
    转录因子LEF1低表达抑制HMGB1致子宫腺肌病患者子宫内膜容受性低下的分子机制
    • 批准号:
      82371704
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      徐步芳
    • 依托单位:
    小鼠肺腺鳞癌转分化类器官模型的建立及表观调控分子机制研究